Sabby Management Has Trimmed By $896,022 Its Tenax Therapeutics (TENX) Stake, Textron (TXT) Shorts Increased By 5.85%

June 27, 2017 - By wolcottdaily

Textron Incorporated (NYSE:TXT) had an increase of 5.85% in short interest. TXT’s SI was 4.45 million shares in June as released by FINRA. Its up 5.85% from 4.20 million shares previously. With 1.61 million avg volume, 3 days are for Textron Incorporated (NYSE:TXT)’s short sellers to cover TXT’s short positions. About 1.67 million shares traded or 24.63% up from the average. Textron Inc. (NYSE:TXT) has risen 23.87% since June 27, 2016 and is uptrending. It has outperformed by 7.17% the S&P500.

Sabby Management Llc decreased Tenax Therapeutics Inc (TENX) stake by 37.14% reported in 2016Q4 SEC filing. Sabby Management Llc sold 896,022 shares as Tenax Therapeutics Inc (TENX)’s stock declined 33.21%. The Sabby Management Llc holds 1.52M shares with $2.96M value, down from 2.41M last quarter. Tenax Therapeutics Inc now has $16.58 million valuation. The stock rose 0.98% or $0.006 reaching $0.586. About 153,367 shares traded. Tenax Therapeutics Inc (NASDAQ:TENX) has declined 81.28% since June 27, 2016 and is downtrending. It has underperformed by 97.98% the S&P500.

Among 12 analysts covering Textron (NYSE:TXT), 8 have Buy rating, 1 Sell and 3 Hold. Therefore 67% are positive. Textron had 15 analyst reports since September 2, 2015 according to SRatingsIntel. The rating was downgraded by Drexel Hamilton to “Hold” on Thursday, January 28. Credit Suisse maintained Textron Inc. (NYSE:TXT) on Thursday, May 25 with “Buy” rating. RBC Capital Markets maintained Textron Inc. (NYSE:TXT) rating on Thursday, January 28. RBC Capital Markets has “Outperform” rating and $47 target. The rating was upgraded by JP Morgan on Wednesday, December 16 to “Overweight”. As per Thursday, June 23, the company rating was initiated by Morgan Stanley. The stock of Textron Inc. (NYSE:TXT) has “Buy” rating given on Wednesday, September 2 by Citigroup. Deutsche Bank maintained the shares of TXT in report on Monday, December 5 with “Hold” rating. Cowen & Co maintained Textron Inc. (NYSE:TXT) on Wednesday, September 9 with “Outperform” rating. Credit Suisse maintained Textron Inc. (NYSE:TXT) rating on Wednesday, April 12. Credit Suisse has “Buy” rating and $50 target. The firm has “Outperform” rating by Robert W. Baird given on Thursday, October 6.

Investors sentiment increased to 1.08 in 2016 Q4. Its up 0.20, from 0.88 in 2016Q3. It improved, as 34 investors sold Textron Inc. shares while 129 reduced holdings. 68 funds opened positions while 108 raised stakes. 222.53 million shares or 3.14% more from 215.76 million shares in 2016Q3 were reported. Victory Cap invested in 2.19M shares. Tudor Inv Corp Et Al accumulated 217,108 shares. Gabelli Funds Ltd Llc has invested 0.27% in Textron Inc. (NYSE:TXT). Synovus Fin holds 0% of its portfolio in Textron Inc. (NYSE:TXT) for 800 shares. Barclays Public Ltd holds 0% of its portfolio in Textron Inc. (NYSE:TXT) for 89,100 shares. Creative Planning invested in 12,942 shares or 0% of the stock. Point72 Asia (Hong Kong) Ltd reported 3,269 shares stake. Mason Street Advisors Ltd Llc has invested 0.05% in Textron Inc. (NYSE:TXT). The Pennsylvania-based Janney Montgomery Scott Ltd Liability has invested 0.03% in Textron Inc. (NYSE:TXT). Qci Asset Management Inc Ny holds 665 shares or 0% of its portfolio. The California-based Whittier Tru has invested 0% in Textron Inc. (NYSE:TXT). Conning Inc reported 6,037 shares. Cwm Lc invested 0% of its portfolio in Textron Inc. (NYSE:TXT). Quantitative Inv Mgmt Ltd Liability Co owns 115,000 shares. Cubist Systematic Strategies Lc invested in 11,021 shares or 0.04% of the stock.

Since February 28, 2017, it had 0 insider purchases, and 1 insider sale for $24,860 activity. Shares for $24,860 were sold by Bamford Mark S on Tuesday, February 28.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts